A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2009
11/11/2009	CN100558712C Therapeutic molecules and methods-1
11/11/2009	CN100558411C Tenascin-C nucleic acid ligands
11/11/2009	CN100558410C Nucleic acids, polypeptides, and methods for modulating apoptosis
11/11/2009	CN100558396C A composition for wound healing and use thereof
11/11/2009	CN100558381C Medicine for curing psoriasis and method of producing the same
11/11/2009	CN100558376C Capsicum ethylsine tablet preparation and its preparation method
11/11/2009	CN100558363C Medicinal composition for treating moist wart
11/11/2009	CN100558361C Methods of improving skin quality
11/11/2009	CN100558340C Use of gourd oil for inhibiting s alpha-reductase activity
11/10/2009	US7615657 Method of producing an oil extract from seeds of plants via a binary azeotropic solvent mixture
11/10/2009	US7615576 Prevention of neutrophil recruitment
11/10/2009	US7615573 Via amino ceramide-like compounds; lowering glycosphingolipid concentrations; Fabry's disease, Gaucher's disease
11/10/2009	US7615562 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents
11/10/2009	US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009	US7615543 Complexes with C-reactive protein (CRP) molecules; rheumatoid arthritis, juvenile chronic (rheumatoid) arthritis, ankylosing spondylitis, psoriatic arthritis, systemic vasculitis, polymyalgia rheumatica, Reiter's disease, Crohn's disease and familial Mediterranean fever
11/10/2009	US7615540 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
11/10/2009	US7615239 Tea for treating dermatitis comprising herbal extracts
11/10/2009	US7615230 Method for decreasing sebum production
11/10/2009	CA2481482C Tropane derivatives as ccr5 modulators
11/10/2009	CA2457952C Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h) one derivatives for neurodegenerative disorders
11/10/2009	CA2411572C 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors
11/10/2009	CA2397614C Honey based wound dressing
11/10/2009	CA2378792C Aminothiazole derivatives and their use as crf receptor ligands
11/10/2009	CA2353460C Carboxylic acids and carboxylic acid isosteres of n-heterocyclic compounds
11/05/2009	WO2009134967A2 Use of nucleic acids with reduced pressure therapy
11/05/2009	WO2009134511A1 Topical compositions for improving appearance of keratinous surfaces
11/05/2009	WO2009134404A2 Steroidal compounds as melanogenesis modifiers and uses thereof
11/05/2009	WO2009134383A2 Vinyl substituted fatty acids
11/05/2009	WO2009134112A1 Pharmaceutical formulation that comprises a bleached extract of ageratina pichinchensis for treating onychomycosis
11/05/2009	WO2009133951A1 Anti-perspiration antigen monoclonal antibody
11/05/2009	WO2009133940A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue
11/05/2009	WO2009133939A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
11/05/2009	WO2009133905A1 Peptide capable of inhibiting activity of human fibroblast growth factor-23 (human fgf-23), and pharmaceutical composition comprising the same
11/05/2009	WO2009133831A1 Phenylpropionic acid derivative and use thereof
11/05/2009	WO2009133692A1 Quinoline compound
11/05/2009	WO2009133136A1 Compounds
11/05/2009	WO2009132821A1 Interleukin (il-21) binding proteins and methods of making and using same
11/05/2009	WO2009112653A3 Cosmetic and/or dermatological composition
11/05/2009	WO2009106991A3 Pyridazine derivatives and their use as therapeutic agents in the treatment of skin disorders
11/05/2009	WO2009099890A3 Methods of treating skin with aromatic skin-active ingredients
11/05/2009	WO2009077693A3 Compositions containing at least one naphthoic acid derivative, benzoyl peroxide and at least one film-forming agent
11/05/2009	WO2009071855A3 Cosmetic or dermatological composition containing an orchid extract, and cosmetic care method using said composition
11/05/2009	WO2009066283A3 Calcium-mediated effects of coral and methods of use thereof
11/05/2009	WO2009044011A3 Use of at least one oxime derivative of 3,5-seco-4-norcholestane as antioxidants
11/05/2009	US20090275646 Therapeutic compounds
11/05/2009	US20090275644 Novel adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof
11/05/2009	US20090275630 Cosmetic composition comprising an imidopercarboxylic acid derivative and a n-acylated amino acid ester
11/05/2009	US20090275611 Compounds Which Modulate The CB2 Receptor
11/05/2009	US20090275576 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
11/05/2009	US20090275527 Skin aging treatment comprising paeoniflorin
11/05/2009	US20090275525 Use of a lactose-derived c-glycoside compound as an agent for activating and regulating cutaneous immunity
11/05/2009	US20090275516 Compounds and method for modulating inflammatory reactions
11/05/2009	US20090274770 Cellular extracts
11/05/2009	US20090274769 Healing composition
11/05/2009	US20090274750 Therapeutic Treatment of Dermatologic Skin Disorders
11/05/2009	US20090274734 Method for obtaining hollow particles
11/05/2009	US20090274707 Anti-IL-12 Antibodies, Nucleic Acids Encoding Antibodies, and Methods of Production
11/05/2009	US20090274691 Use of CD25 binding molecules in steroid-resistant patients
11/05/2009	US20090274680 Human Phospholipases
11/05/2009	US20090274677 Antioxidant for use in cosmetic, medicated and pharmaceutical preparations
11/05/2009	US20090274673 Composition for topical treatment of acne
11/05/2009	CA2729053A1 Vinyl substituted fatty acids
11/05/2009	CA2722906A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue
11/05/2009	CA2722852A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
11/05/2009	CA2722671A1 Use of nucleic acids with reduced pressure therapy
11/05/2009	CA2722270A1 Steroidal compounds as melanogenesis modifiers and uses thereof
11/04/2009	EP2113509A2 Modulation of the expression of STAT-1 dependent genes
11/04/2009	EP2113245A2 Substances capable of potentiating laminin 5 productivity in epidermal cells and their use
11/04/2009	EP2113230A2 Drug-Delivery Endovascular Stent and Method for Treating Restenosis
11/04/2009	EP2112929A1 Herbal formulation for wound healing
11/04/2009	EP1723952B1 Antiwrinkling preparation
11/04/2009	EP1481077B1 Mitotic kinesin inhibitors
11/04/2009	EP1480736B1 Microcapsules having high carotenoid content
11/04/2009	EP1467743B1 Pharmaceutical combinations comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application
11/04/2009	EP1455773B1 2-aryl-propionic acids and pharmaceutical compositions containing them
11/04/2009	EP1432700B1 Spiro-hydantoin compounds useful as anti-inflammatory agents
11/04/2009	EP1420645B1 Multivesicular emulsion topical delivery systems
11/04/2009	EP1311488B1 Substituted imidazoles as tafia inhibitors
11/04/2009	EP1261623B1 New retinol derivatives, the method of preparations and the uses thereof
11/04/2009	EP1204430B1 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes
11/04/2009	CN101573131A Anti-connexin compounds and uses thereof
11/03/2009	US7612238 Such as (R)-2-amino-2-methyl-4-[4-(4,4,5,5,5-pentafluoro-pentyloxy)-phenyl]-butan-1-ol hydrochloride for treatment of disorders or diseases mediated by lymphocytes, and for treating acute or chronic transplant rejection or T-cell-mediated inflammatory or autoimmune diseases
11/03/2009	US7612110 Immunosuppressants; for use in transplantation medicine or treatment of autoimmune diseases such as polyarthritis but not psoriatitc arthritis; micro-tablets, pellets
11/03/2009	US7612094 Tri-substituted heteroaryls and methods of making and using the same
11/03/2009	US7612092 Nitrogen-containing aromatic derivatives
11/03/2009	US7612083 Urea substituted imidazoquinoline ethers
11/03/2009	US7612079 2-(hydroxypiperidin-1-yl or hydroxyisoalkylamino)-6(3-nitrophenylamino, 3,4-dimethoxybenzylamino, pyrid-2-yl-methylamino, pyrid-4-yl-methylamino or indan-5-amino)-9-(isopropyl or cyclopentyl)purines; cell cyclin kinase inhibitors for treating cancer, leukemia, psoriasis and neuronal apoptosis
11/03/2009	US7611708 Methods of therapy for B-cell malignancies using antagonist anti-CD40 antibodies
11/03/2009	CA2420585C Amides of r-2-(aminoaryl)-propionic acids for use in the prevention of leucocyte activation
11/03/2009	CA2418961C Anti-il-12 antibodies, compositions, methods and uses
11/03/2009	CA2418008C Antifungal ketoconazole composition for topical use
11/03/2009	CA2415272C Improvements in and relating to the use of honey in dressings
11/03/2009	CA2404210C Pharmaceutical gel composition
11/03/2009	CA2181548C Zinc finger protein derivatives and methods therefor
10/2009
10/29/2009	WO2009132093A2 Substituted arylcyclopentenes as therapeutic agents
10/29/2009	WO2009132085A1 Substituted arylcyclopentenes as prostaglandin ep2 agonists
10/29/2009	WO2009131395A2 Angiogenic peptide
10/29/2009	WO2009131171A1 Novel five-membered ring compound
10/29/2009	WO2009131170A1 Five-membered ring compound
10/29/2009	WO2009131065A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient

1 ... 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 ... 1065